Bra podd
Topplistor
Samhälle och kultur
Barn och familj
Fritid
Hälsa och motion
Historia
Komedi
Konst och kultur
Musik
Näringsliv
Nyheter och politik
Poddtoppen
Religion och spiritualitet
Skönlitteratur
Sport och fritid
Stat och kommun
Teknik
Tv och film
Utbildning
Verkliga brott
Vetenskap
Kategorier
Konst
(1647)
Religion och spiritualitet
(1586)
Utbildning
(1435)
Samhälle och kultur
(1373)
Fritid
(1205)
Musik
(1121)
Teknologi
(1123)
Vetenskap
(1034)
TV och film
(1014)
Nyheter
(952)
Historia
(909)
Hälsa och motion
(800)
Näringsliv
(812)
Barn och familj
(798)
Skönlitteratur
(741)
Kristendom
(612)
Komedi
(527)
Böcker
(542)
Verkliga brott
(455)
Sport
(470)
Andlighet
(435)
Självhjälp
(418)
Stat och kommun
(404)
Hobbies
(319)
Sällskapsspel
(309)
Drama
(286)
Mental hälsa
(283)
Musikkommentarer
(272)
Musikintervjuer
(253)
Föräldraskap
(251)
Spel
(250)
Politik
(239)
Dokumentär
(229)
Språkkurs
(220)
Samhällsvetenskap
(197)
Science fiction
(193)
Mat
(166)
Dans och teater
(165)
Entreprenörskap
(165)
Filmrecensioner
(165)
Tekniknyheter
(163)
Investering
(155)
Islam
(159)
TV-recensioner
(150)
Så gör man
(151)
Mode och skönhet
(143)
Musikhistoria
(146)
Efterprogram
(141)
Visuell konst
(141)
Personliga dagböcker
(136)
Berättelser för barn
(138)
Relationer
(132)
Naturvetenskap
(130)
Design
(127)
Nyhetskommentarer
(117)
Natur
(106)
Hus och trädgård
(104)
Karriär
(98)
Filmhistoria
(101)
Life Science
(101)
Filosofi
(99)
Alternativ hälsa
(98)
Fotboll
(98)
Kurser
(97)
Utbildning för barn
(92)
Djur
(82)
Fordon
(89)
Medicin
(88)
Komedifiktion
(89)
Ledarskap
(86)
Underhållningsnyheter
(77)
Religion
(72)
Filmintervjuer
(66)
Affärsnyheter
(65)
Hantverk
(64)
Komediintervjuer
(64)
Dagliga nyheter
(63)
Marknadsföring
(48)
Motion
(52)
Näringslära
(51)
Sportnyheter
(46)
Sexualitet
(41)
Buddhism
(41)
Judendom
(41)
Hockey
(40)
Geovetenskap
(37)
Fysik
(35)
Platser och resor
(34)
Ideell
(30)
Astronomi
(29)
Löpning
(27)
Amerikansk fotboll
(26)
Flyg
(24)
Vildmarken
(24)
Animering och manga
(22)
Improvisering
(21)
Golf
(10)
Hinduism
(14)
Matematik
(14)
Kemi
(12)
Basket
(9)
Fantasysporter
(8)
Tennis
(8)
Baseball
(3)
Ståupp
(7)
Brottning
(2)
Cricket
(2)
Rugby
Simning
Start
/
BioCentury This Week
/
Ep 25 alzheimer milestones vaccine politics
BioCentury This Week
Ep. 25 - Alzheimer Milestones & Vaccine Politics
13 min • 29 september 2020
Spela avsnitt
Reach us by sending a text
Spela avsnitt
Senaste avsnitt
Play
Pause
Ep. 310 - Sarepta & What's Next for Gene Therapy. Plus: Leading FDA's CDER
22 juli | 32 min
Play
Pause
Ep. 309 - 3Q Markets Preview; Quantum Computing; Makary’s First 100 Days
14 juli | 37 min
Play
Pause
Ep. 308 - Grand Rounds - Europe Preview
9 juli | 31 min
Play
Pause
Ep. 307 - How Cancer Regulation is — and isn’t — Changing at FDA
8 juli | 30 min
Play
Pause
Ep. 306 - Treg Inflection Point; Biotech's Next Big Story; Tax Bill Consequences
8 juli | 32 min
Play
Pause
Ep. 305 - FDA's Future; In Vivo CAR T Plays; Psychedelics; CDK2
1 juli | 39 min
Play
Pause
Ep. 304 - Syncona Reshapes Fund; Lilly's $1B Verve Bet; FDA's 2-Track Future
24 juni | 35 min
Play
Pause
Ep. 303 - Gene Therapy Safety, Amylin in Obesity & FDA's Future
16 juni | 34 min
Play
Pause
Ep. 302 - Takeaways from BioCentury Grand Rounds Chicago
12 juni | 31 min
Play
Pause
Ep. 301 - ASCO’s First-in-Human Trials, Crossover Investors & FDA's Rare Disease Plans
10 juni | 36 min
Play
Pause
Ep. 300 - Biotech’s $13B Deal Day, ASCO's Hot Targets, Drug Pricing Threat
3 juni | 39 min
Play
Pause
Ep. 299 - ASCO, EpCAM, Rocket & HK IPOs
28 maj | 31 min
Play
Pause
Ep. 298 - Takeaways from the 25th Bio€quity Europe
23 maj | 39 min
Play
Pause
Ep. 297 - European Biotech's Moment? Plus: Biomarin, Boston Deals & Novo Nordisk CEO
20 maj | 36 min
Play
Pause
Ep. 296 - Trends in Obesity, Vinay Prasad at FDA, Ovarian Cancer Insights
13 maj | 33 min
Play
Pause
Ep. 295 - Bio€quity Europe 2025 Preview
9 maj | 29 min
Play
Pause
Ep. 294 - AACR Spotlight on SMARCA2 degraders. Plus: David Baker, Drug Pricing
6 maj | 31 min
Play
Pause
Ep. 293 - Tau Time for Alzheimer's. Plus: FDA Delays, Merck's $4B Deal, HK IPOs
29 april | 31 min
Play
Pause
Ep. 292 - Myasthenia Gravis Spotlight & AACR Preview
26 april | 26 min
Play
Pause
Ep. 291 - Grand Rounds - U.S. Preview
25 april | 31 min
Play
Pause
Ep. 290 - Biotech Survey Sees Tough Days Ahead. Plus: FDA, China Speed
22 april | 38 min
Play
Pause
Ep. 289 - Replacing Animal Models. Plus: RFK Jr. & FDA
15 april | 37 min
Play
Pause
Ep. 288 - FDA and Tariffs Turmoil, and AACR Preview
8 april | 27 min
Play
Pause
Ep. 287 - The Bear is Back: Marks’ Ouster, Tariffs and a Tumbling XBI
1 april | 26 min
Play
Pause
Ep. 286 - Sofinnova’s Pan-European Accelerator, China Biotechs, Trump Tariffs
25 mars | 25 min
Play
Pause
Ep. 285 - BIO's Trump 2.0 Plan. Plus: Autoimmune CAR Ts & Telix's Radiopharma Play
18 mars | 28 min
Play
Pause
Ep. 284 - Takeaways from the East-West Summit
12 mars | 41 min
Play
Pause
Ep. 283 - Makary’s FDA Agenda, Amylin in Obesity and Life After DEI
11 mars | 32 min
Play
Pause
Ep. 282 - CRISPR Lessons: Plus, AbbVie Enters Obesity
4 mars | 24 min
Play
Pause
Ep. 281 - Roche Reboot and 5 Things on Trump 2.0
25 februari | 22 min
Play
Pause
Ep. 280 - China Competition. Plus: FDA Firings and Biotech IPOs
19 februari | 28 min
Play
Pause
Ep. 279 - East-West Summit Preview
15 februari | 30 min
Play
Pause
Ep. 278 - Trump 2.0’s Impact on FDA, NIH. Plus: Precision Medicine
11 februari | 26 min
Play
Pause
Ep. 277 - Asia's NewCo Model, FDA Tipping Point, Vertex's Pain Drug
4 februari | 25 min
Play
Pause
Ep. 276 - Precision Neuropsychiatry Spotlight With ICON's Peter Schueler
31 januari | 21 min
Play
Pause
Ep. 275 - Series As & Innovation. Plus: Rocky Transition at FDA, NIH
28 januari | 33 min
Play
Pause
Ep. 274 - 2025 Biotech Preview: Markets, Catalysts and AI
22 januari | 36 min
Play
Pause
Ep. 273 - JPM 2025 Wrap: Sunny Skies & Megarounds
17 januari | 22 min
Play
Pause
Ep. 272 - JPM Deal Buzz & Rep. Auchincloss’ Take on Biopharma
13 januari | 27 min
Play
Pause
Ep. 271 - Biotech in the New Year. Plus: Beyond Biosecure
7 januari | 35 min
Play
Pause
Ep. 270 - Temple’s FDA Legacy. Plus: Chinese Innovation & Novo Obesity Data
30 december 2024 | 35 min
Play
Pause
Bonus Content - Trends in Global Biopharma Deals: Lazard’s Kingston and Raine
23 december 2024 | 35 min
Play
Pause
Ep. 269 - Trends in VC Funds, Obesity Start-ups and More
17 december 2024 | 33 min
Play
Pause
Ep. 268 - Biosecure Setback & Novartis' $1B PTC Deal
10 december 2024 | 22 min
Play
Pause
Ep. 267 - Trump's NIH Pick & Multi-targeted CAR Ts
3 december 2024 | 27 min
Play
Pause
Ep. 266 - Jefferies Recap, FDA Commissioner & Biosecure Update
26 november 2024 | 27 min
Play
Pause
Ep. 265 - RFK Jr. & HHS, Blenrep's Comeback, China Deals
19 november 2024 | 30 min
Play
Pause
Ep. 264 - Prepping for Trump & Alzheimer's Ethics
12 november 2024 | 29 min
Play
Pause
Ep. 263 - Alzheimer Insights: Anti-Amyloid Safety & Tau Teaser
5 november 2024 | 35 min
Play
Pause
Ep. 262 - EGFR Case Study, FDA & Politics
29 oktober 2024 | 24 min
Play
Pause
Ep. 261 - China Summit: Reinventing Your China Strategy
24 oktober 2024 | 32 min
Play
Pause
Ep. 260 - VC Funds, New Chapter for MS, Wave's Data
22 oktober 2024 | 31 min
Play
Pause
Ep. 259 - Causal Biology and Big Data, Ultra-Rare Drugs at FDA
15 oktober 2024 | 34 min
Play
Pause
Ep. 258 - Breaking the Bear: 4Q Public Markets Preview
8 oktober 2024 | 40 min
Play
Pause
Ep. 257 - Schizophrenia, Sickle Cell Drugs, D.C. Update
1 oktober 2024 | 32 min
Play
Pause
Ep. 256 - ESMO Recap: Keeping TIGIT Alive, Rybrevant & Immunotherapy Anniversary
26 september 2024 | 27 min
Play
Pause
Ep. 255 - Pediatric PRVs, Biosecure & Novo's Obesity Miss
24 september 2024 | 22 min
Play
Pause
Ep. 254 - Takeaways from Grand Rounds 2024
20 september 2024 | 35 min
Play
Pause
Ep. 253 - IPOs, GLP-1 & Obesity, AI & Biotech
17 september 2024 | 33 min
Play
Pause
Ep. 252 - Akeso's Bispecific, Vaxcyte & Woodcock's Quality Mindset
10 september 2024 | 19 min
Play
Pause
Ep. 251 - Eyes on the target: a Back to School Overview
7 september 2024 | 32 min
Play
Pause
Ep. 250 - Biosecure, Priority Review Vouchers & Target Discovery
4 september 2024 | 30 min
Play
Pause
Ep. 249 - Biotech IPO Buzz, Pharma Deal Trends, Washington Update
27 augusti 2024 | 29 min
Play
Pause
Ep. 248 - Grand Rounds Preview: Eyes on the Target
23 augusti 2024 | 34 min
Play
Pause
Ep. 247 - Drug Pricing, Psychedelic Setback & Back to School
20 augusti 2024 | 26 min
Play
Pause
Ep. 246 - Wilson’s Vision for Gene Therapy. Plus: Korea Biotech & Grand Rounds
13 augusti 2024 | 32 min
Play
Pause
Ep. 245 - Biotech-Academia Deals, Leqembi's Latest, Wilson Moves On
6 augusti 2024 | 26 min
Play
Pause
Ep. 244 - Leqembi's Thumbs-Down in Europe. Plus: Perioperative Cancer, Pediatric Review Vouchers
30 juli 2024 | 30 min
Play
Pause
Ep. 243 - Radiopharma Alpha Emitters, AZ’s Galbraith and LNPs
23 juli 2024 | 29 min
Play
Pause
Ep. 242 - 3Q Markets Preview, Washington Update, Lisa Burns
16 juli 2024 | 26 min
Play
Pause
Ep. 241 - U.K. Biopharma on the Move. Plus: IRA, Biosecure
9 juli 2024 | 19 min
Play
Pause
Ep. 240 - Chevron Ruling's Impact. Plus: Tumor Targets, Lurie Winner
2 juli 2024 | 21 min
Play
Pause
Ep. 239 - Rare Disease Spotlight: MPS & DMD
25 juni 2024 | 25 min
Play
Pause
Ep. 238 - Biosecure Act: The Impact & What's Ahead
20 juni 2024 | 22 min
Play
Pause
Ep. 237- Pandemic Prep Problems, Reverse Mergers, Alzheimer’s & SCOTUS
18 juni 2024 | 29 min
Play
Pause
Ep. 236 - BIO Wrap: Biosecure, Japan & Nxera, Radiopharma
14 juni 2024 | 26 min
Play
Pause
Ep. 235 - Psychedelic Setback, FDA's Platform Play & ASCO Innovations
10 juni 2024 | 30 min
Play
Pause
Ep. 234 - Biotech M&A, Biosecure Expands & ASCO Update
3 juni 2024 | 29 min
Play
Pause
Ep. 233 - ASCO Preview, Rare Diseases & Biogen M&A
28 maj 2024 | 27 min
Play
Pause
Ep. 232 - Shake up at BIO. Plus: ASGCT highlights, new IPF & obesity data
20 maj 2024 | 26 min
Play
Pause
Bonus Content - Derek Lowe Unplugged: AI; Biosecure; FDA, Abortion & SCOTUS; and more
16 maj 2024 | 33 min
Play
Pause
Ep. 231 - Biosecure Revised. Plus: Venture Rounds, Deals of Note
14 maj 2024 | 25 min
Play
Pause
Bonus Content - Ysios' Karen Wagner: How Europe's Biotechs Can Rise Above the Noise
9 maj 2024 | 32 min
Play
Pause
Ep. 230 - Bio€quity Europe 2024 Preview
9 maj 2024 | 26 min
Play
Pause
Ep. 229 - ASGCT Preview, Accelerated Approval Plus: The Latest in Biosecure
7 maj 2024 | 29 min
Play
Pause
Ep. 228 - Energizing Gene Therapy. Plus: AI Newco, Ono-Deciphera
30 april 2024 | 23 min
Play
Pause
Ep. 227 - Defending Accelerated Approval. Plus: Endpoint Innovation & AIM Amiss
22 april 2024 | 23 min
Play
Pause
Ep. 226 - Vertex’s Alpine Buy, Goldman’s Venture & IRA Tea Leaves
16 april 2024 | 23 min
Play
Pause
Ep. 225 - 2Q Markets Preview & AACR Takeaways
8 april 2024 | 22 min
Play
Pause
Ep. 224 - Biotech IPOs, Avalon & FDA at SCOTUS
2 april 2024 | 21 min
Play
Pause
Ep. 223 - Biosecure, Bruce Booth & Ultrarare Drugs
26 mars 2024 | 28 min
Play
Pause
Ep. 222 - Crowley’s Vision for BIO, Plus: MASH & CAR Ts
18 mars 2024 | 21 min
Play
Pause
Ep. 221 - China Biocontroversy, Plus: Diversity Matters
12 mars 2024 | 32 min
Play
Pause
Ep. 220 - Biotech’s Financing Flurry & Distillery Spotlight
5 mars 2024 | 24 min
Play
Pause
Ep. 219 - East-West Summit Preview
28 februari 2024 | 25 min
Play
Pause
Ep. 218 - Bob Nelsen Insights, TL1A, Rare Diseases
27 februari 2024 | 25 min
Play
Pause
Ep. 217 - Safer CAR Ts & World’s First TIL Therapy
21 februari 2024 | 25 min
Play
Pause
Ep. 216 - Anti-China Biotech Policy: Biosecure & Beyond
16 februari 2024 | 27 min
Play
Pause
Ep. 215 - ADCs, Psychedelics & IPOs
13 februari 2024 | 25 min
Play
Pause
Ep. 214 - BMS’s Patent Cliff, Congress Targets China Biotech
6 februari 2024 | 30 min
Play
Pause
Ep. 213 - Biotech IPOs & IL-18 Momentum
30 januari 2024 | 28 min
Play
Pause
Ep. 212 - 2024 Buyside View & Arnold Ventures' Impact
23 januari 2024 | 30 min
Play
Pause
Ep. 211 - 2024 Markets Preview, Woodcock's Legacy
17 januari 2024 | 22 min
Play
Pause
Ep. 210 - J.P. Morgan Healthcare Conference Wrap
13 januari 2024 | 27 min
Play
Pause
Ep. 209 - Biotech M&A, Innovation, Public Policy in 2024
5 januari 2024 | 38 min
Play
Pause
Ep. 208 - XBI Rally, ASH Highlights & '24 Picks
19 december 2023 | 24 min
Play
Pause
Ep. 207 - Sickle Cell, AbbVie Deals, BIO CEO, March-in
12 december 2023 | 31 min
Play
Pause
Ep. 206 - Roche, AbbVie Deals; Plus: FDA & CAR T
5 december 2023 | 20 min
Play
Pause
Ep. 205 - Radiotherapy Deep Dive; Plus: Congress, BioNTech
28 november 2023 | 25 min
Play
Pause
Ep. 204 - First CRISPR Approval & IRA’s Lost Orphans
20 november 2023 | 29 min
Play
Pause
Ep. 203 - POC for Verve? Plus: IRA & East-West Deals
14 november 2023 | 21 min
Play
Pause
Ep. 202 - A DMD Decision & Endpoint Innovation
7 november 2023 | 30 min
Play
Pause
Ep. 201 - ESMO, NIH & IRA
30 oktober 2023 | 18 min
Play
Pause
Ep. 200 - Merck-Daiichi, Roche-Roivant, Base Editors
24 oktober 2023 | 28 min
Play
Pause
Ep. 199 - China Summit Preview
20 oktober 2023 | 24 min
Play
Pause
Ep. 198 - Novartis Finds Focus & EU Pharma Law
16 oktober 2023 | 28 min
Play
Pause
Ep. 197 - Mirati Takeout & 4Q23 Financial Markets Preview
9 oktober 2023 | 29 min
Play
Pause
Ep. 196 - CAR T's Next Act & Hudson's Vision for Sanofi
3 oktober 2023 | 29 min
Play
Pause
Ep. 195 - East-West Summit Preview
25 september 2023 | 20 min
Play
Pause
Ep. 194 - IPO Outlook & IRA Lawsuits
19 september 2023 | 24 min
Play
Pause
Ep. 193 - East-West CAR T Deals, Plus: Amgen-FTC
12 september 2023 | 23 min
Play
Pause
Ep. 192 - Tier-jumpers: a Back to School Overview
5 september 2023 | 33 min
Play
Pause
Ep. 191 - Circular RNA, Psychedelics, & Upcoming BioCentury Summits
22 augusti 2023 | 23 min
Play
Pause
Ep. 190 - Obesity Mechanisms, Noubar Takeaways, Scleroderma Platform Trial
14 augusti 2023 | 18 min
Play
Pause
Ep. 189 - Biogen-Sage Setback, Biotech IPOs, Sanofi Digital
7 augusti 2023 | 23 min
Play
Pause
Ep. 188 – Pharma deals; Plus: Genentech, Leerink Conversations
31 juli 2023 | 26 min
Play
Pause
Ep. 187 - Alnylam-Roche; Plus: Insights on the IRA, FTC
24 juli 2023 | 25 min
Play
Pause
Ep. 186 - 3Q Markets Preview, Donanemab & Lilly-Versanis
17 juli 2023 | 19 min
Play
Pause
Ep. 185 - Leqembi's Launch, Biotech IPOs, Sarepta Approval
11 juli 2023 | 26 min
Play
Pause
Ep. 184 - Califf's FDA reforms & Polaris' Schulman
26 juni 2023 | 27 min
Play
Pause
Ep. 183 - EMA's Cooke, What's Next for IPSCs, & Leerink is Back
19 juni 2023 | 30 min
Play
Pause
Ep. 182 - Merck’s IRA suit, Leqembi and MCEDs at ASCO
13 juni 2023 | 30 min
Play
Pause
Ep. 181 - Highlights from ASCO
5 juni 2023 | 26 min
Play
Pause
Ep. 180 - ASCO, Neuropsych & the IRA
30 maj 2023 | 20 min
Play
Pause
Ep. 179 - DMD Gene Therapies, CBER & NIH
23 maj 2023 | 27 min
Play
Pause
Ep. 178 - Live from Bio€quity, Part 2
16 maj 2023 | 20 min
Play
Pause
Ep. 177 - Live from Bio€quity, Part 1
15 maj 2023 | 22 min
Play
Pause
Ep. 176 - Bio€quity Europe 2023 Preview: Crafting a European Playbook for Success
9 maj 2023 | 23 min
Play
Pause
Ep. 175 - Acelyrin IPO, Alzheimer's Data & Digital Endpoints
9 maj 2023 | 25 min
Play
Pause
Ep. 174 - EC Pharma Law, ALS Biomarker, Astellas' Iveric Deal
1 maj 2023 | 25 min
Play
Pause
Ep. 173 - EU VC Funds, Abortion Drug Ruling, IRA Insights
25 april 2023 | 23 min
Play
Pause
Ep. 172 - AACR Insights
20 april 2023 | 23 min
Play
Pause
Ep. 171 - 2Q Markets Preview, Abortion Drug Rulings, Gilead Oncology
17 april 2023 | 28 min
Play
Pause
Ep. 170 - Abortion Ruling & FDA; New VC Funds; IRA
10 april 2023 | 20 min
Play
Pause
Ep. 169 - FTC & Illumina, Plus: PCSK9s at SCOTUS
3 april 2023 | 23 min
Play
Pause
Ep. 168 - VCs' Take on SVB & New ALS Endpoint
27 mars 2023 | 21 min
Play
Pause
Ep. 167 - The IRA, T Cell Therapies & The Distillery
21 mars 2023 | 22 min
Play
Pause
Ep. 166 - SVB Shakeout: Next Steps for Biotech
17 mars 2023 | 24 min
Play
Pause
Ep. 165 - SVB Fallout, Plus: Pfizer-Seagen
13 mars 2023 | 25 min
Play
Pause
Ep. 164 - Viehbacher’s Vision, NK Cells & Bat Biotech
7 mars 2023 | 27 min
Play
Pause
Ep. 163 - EU Pharma Law Overhaul, Abortion Drug Ruling, Dunn's Departure
28 februari 2023 | 25 min
Play
Pause
Ep. 162 - New CMS Payment Models, China Markets Outlook, & Zhang's Latest Start-Up
21 februari 2023 | 22 min
Play
Pause
Ep. 161 - New Cancer Paradigms, Distilling Innovations, & IPOs
13 februari 2023 | 17 min
Play
Pause
Ep. 160 - Dose Optimization, Clinical Trials Diversity and QALYs
7 februari 2023 | 25 min
Play
Pause
Ep. 159 - BIO's Priorities, ESG & Venture Trends
31 januari 2023 | 24 min
Play
Pause
Ep. 158 - CAR T Manufacturing & Orphan Drugs
24 januari 2023 | 30 min
Play
Pause
Ep. 157 - 2023 Markets Outlook & Buyside Picks
18 januari 2023 | 27 min
Play
Pause
Ep. 156 - JPM Highlights & Alzheimer's Takeaways
9 januari 2023 | 31 min
Play
Pause
Ep. 155 - U.K. Biotech, Aduhelm, 2022 Approval Trends
4 januari 2023 | 35 min
Play
Pause
Ep. 154 - Madrigal in NASH, Moderna & Neoantigens, the Distillery
20 december 2022 | 19 min
Play
Pause
Ep. 153 - The Inflation Reduction Act
19 december 2022 | 19 min
Play
Pause
Ep. 152 - Amgen's Horizon Takeout. Plus: ASH, SERDs
13 december 2022 | 18 min
Play
Pause
Ep. 151 - Alzheimer's Takeaways, U.K. Biotech, Charles Forum
6 december 2022 | 27 min
Play
Pause
Ep. 150 - Model Term Sheets, Pragmatic Trials & Gene Therapy Prices
28 november 2022 | 19 min
Play
Pause
Ep. 149 - Takeaways from the East-West Summit
21 november 2022 | 22 min
Play
Pause
Ep. 148 - East-West Summit Highlights Part 2
18 november 2022 | 23 min
Play
Pause
Ep. 147 - East-West Summit Highlights Part 1
16 november 2022 | 26 min
Play
Pause
Ep. 146 - What's Next in Washington, Plus: SITC & the Distillery
15 november 2022 | 19 min
Play
Pause
Ep. 145 - What's Next for BIO, Plus: Pfizer, GSK
7 november 2022 | 21 min
Play
Pause
Ep. 144 - Alnylam's IRA Pause, Plus Argenx & Accumulus
31 oktober 2022 | 25 min
Play
Pause
Ep. 143 - East-West Summit Preview
28 oktober 2022 | 24 min
Play
Pause
Ep. 142 - Lundbeck, Biogen, Biden & Biomanufacturing, Nora Volkow
25 oktober 2022 | 26 min
Play
Pause
Ep. 141 - Neoantigen Vaccines, Drug Pricing, U.S.-China & U.K. Turmoil
17 oktober 2022 | 26 min
Play
Pause
Ep. 140 - Turbulence at BIO, Plus 4Q Preview & the Distillery
11 oktober 2022 | 29 min
Play
Pause
Ep. 139 - Wins in Neurodegeneration, U.S.-China & Life Science Cares
4 oktober 2022 | 27 min
Play
Pause
Ep. 138 - FDA User Fee Endgame, East-West Summit & Biogen
27 september 2022 | 28 min
Play
Pause
Ep. 137 - Intellia's Data, IRA's Orphan Impact, CFIUS Order
19 september 2022 | 19 min
Play
Pause
Ep. 136 - IRA, KRAS & ESMO
13 september 2022 | 23 min
Play
Pause
Ep 135 Pt. 5 - A Portrait of Biopharma's New Leaders
2 september 2022 | 19 min
Play
Pause
Ep 135 Pt. 4 - Filling Biopharma's Talent Pipeline
1 september 2022 | 16 min
Play
Pause
Ep 135 Pt. 3 - Rising Leaders & the VC View on Talent
31 augusti 2022 | 16 min
Play
Pause
Ep 135 Pt. 2 - CEOs in the Spotlight. Plus: Women Leaders, DEI
30 augusti 2022 | 19 min
Play
Pause
Ep 135 Pt. 1 - Back to School 2022 Overview
29 augusti 2022 | 16 min
Play
Pause
Ep. 134 - Preclinical Deal Making, Bluebird's Approval & Epigenome Editing
22 augusti 2022 | 20 min
Play
Pause
Ep. 133 - Financing Thaw? Plus: Protein Design & China Audits
16 augusti 2022 | 19 min
Play
Pause
Ep. 132 - M&A & Data: recipe for a rebound?
9 augusti 2022 | 20 min
Play
Pause
Ep. 131 - Seagen, New Modalities & Structure
2 augusti 2022 | 18 min
Play
Pause
Ep. 130 - Steady as a Roche. Plus: Washington Turbulence
25 juli 2022 | 20 min
Play
Pause
Ep. 129 - Burr Bill, Novartis Makeover, ALS Update
19 juli 2022 | 21 min
Play
Pause
Ep. 128 - Financial Markets Forecast, AAV Toxicity & Drug Pricing
12 juli 2022 | 23 min
Play
Pause
Ep. 127 - TeneoTwo, Lightspeed, Arch & The Distillery
6 juli 2022 | 29 min
Play
Pause
Ep. 126 - Growing Galapagos, Plus Abortion & Biopharma
28 juni 2022 | 26 min
Play
Pause
Ep. 125 - Next Steps for ARPA-H
21 juni 2022 | 25 min
Play
Pause
Ep. 124 - CRISPR's High Bar, Private Equity Inroads and the Distillery
13 juni 2022 | 27 min
Play
Pause
Ep. 123 - Fixing FDA's Broken Advisory Panels
8 juni 2022 | 21 min
Play
Pause
Ep. 122 - ASCO's Advances & Fixes for FDA's AdComms
7 juni 2022 | 26 min
Play
Pause
Ep. 121 - ASCO, CRISPR IP & CStone
1 juni 2022 | 22 min
Play
Pause
Ep. 120 - Next-gen NK cells, Plus Woodcock & BMS’s Russian Withdrawal
23 maj 2022 | 21 min
Play
Pause
Ep. 119 - Bio€quity Recap, Part 2
19 maj 2022 | 20 min
Play
Pause
Ep. 118 - Bio€quity Recap, Part 1
18 maj 2022 | 23 min
Play
Pause
Ep. 117 - Sofinnova Partners’ Growth Deal, Plus Distillery on Tap
17 maj 2022 | 22 min
Play
Pause
Ep. 116 - The Road to Bio€quity 2022: Navigating Through Talent & Capital Headwinds
12 maj 2022 | 22 min
Play
Pause
Ep. 115 - FDA Reform on Deck, Plus Translation at Howard
10 maj 2022 | 18 min
Play
Pause
Ep. 114 - Hutchmed Setback, FDA in Focus, HilleVax's IPO
3 maj 2022 | 21 min
Play
Pause
Ep. 113 - Nkarta’s Breakthrough, Hatch’s Legacy & Shanghai’s Lockdown
26 april 2022 | 21 min
Play
Pause
Ep. 112 - Digesting DDR Data; Plus Sharpless’ Legacy, McKinsey’s Conflicts
19 april 2022 | 20 min
Play
Pause
Ep. 111 - Seeking Green Shoots Amid Biotech’s Gloom
14 april 2022 | 18 min
Play
Pause
Ep. 110 - Aduhelm’s Lessons, Plus Distillery Discoveries, Rare Disease Innovation
12 april 2022 | 24 min
Play
Pause
Ep. 109 - What's Next for Novartis? Plus: AACR, Merck KGaA
5 april 2022 | 20 min
Play
Pause
Ep. 108 - AACR Preview for CAR Ts in Solid Tumors; Plus FDA Weighs in on Data for ALS Ad Com
29 mars 2022 | 19 min
Play
Pause
Ep. 107 - A Tale of Two Targets: LAG3, IL-2; Plus Alternatives to Cash Up
22 mars 2022 | 21 min
Play
Pause
Ep. 106 - China's C-suite Hears FDA, Plus AACR, ARPA-H
15 mars 2022 | 22 min
Play
Pause
Ep. 105 - War Pulls Biotech to Ukraine, Out of Russia
8 mars 2022 | 22 min
Play
Pause
Ep. 104 - Biotech Shows Support for Ukraine, Plus Latest Intellia Data
1 mars 2022 | 22 min
Play
Pause
Ep. 103 - Califf’s Priorities for Second Stint as FDA Commissioner
23 februari 2022 | 23 min
Play
Pause
Ep. 102 - What FDA's Tyvyt Precedent Means for China; plus Translational Trendspotting
15 februari 2022 | 21 min
Play
Pause
Ep. 101 - Of Biotech Bears, Pazdur & PDUFA
8 februari 2022 | 29 min
Play
Pause
Ep. 100 - Capital markets check in; plus Belgium’s prodigal son returns
1 februari 2022 | 27 min
Play
Pause
Ep. 99 - Introducing The BioCentury Show, Plus Califf, COVID and GSK
25 januari 2022 | 26 min
Play
Pause
Ep. 98 - Bargain Hunting in a Rocky Market, plus Advantage, CMS
19 januari 2022 | 24 min
Play
Pause
Ep. 97 - Buysiders' Picks, plus JPM22 roundup
11 januari 2022 | 28 min
Play
Pause
Ep. 96 - Aduhelm, Pazdur, Pharma Digital & '21 Wrap
21 december 2021 | 23 min
Play
Pause
Ep. 95 - ASH's New Targets, Avistone & Washington Update
14 december 2021 | 20 min
Play
Pause
Ep. 94 - Woodcock's To-Do List, Maraganore's Takeaways & the Distillery
7 december 2021 | 23 min
Play
Pause
Ep. 93 - Omicron's Open Questions, Plus the Business Case for Ultra-rare Diseases
30 november 2021 | 20 min
Play
Pause
Ep. 92 - Biogen’s R&D decision, previewing TIGIT & China Summit highlights
22 november 2021 | 23 min
Play
Pause
Ep. 91 - China Summit Highlights: Day 2
18 november 2021 | 39 min
Play
Pause
Ep. 90 - China Summit Highlights: Day 1
17 november 2021 | 36 min
Play
Pause
Ep. 89 - Califf's Passions, RWE in China & LSP Rising
16 november 2021 | 33 min
Play
Pause
Ep. 88 - China Summit Preview: The Bridge to Innovation
10 november 2021 | 28 min
Play
Pause
Ep. 87 - Digesting Drug Pricing, Plus Access in ALS
9 november 2021 | 33 min
Play
Pause
Ep. 86 - Woodcock's Legacy, Plus Frazier, Bain & the Distillery
2 november 2021 | 27 min
Play
Pause
Ep. 85 - What's Next for CRISPR & Gene Therapy, Plus China Summit Preview
26 oktober 2021 | 23 min
Play
Pause
Ep. 84 - Why Gene Therapy's Bad Year Is a Speed Bump, Not a Dead End
22 oktober 2021 | 23 min
Play
Pause
Ep. 83 - Assessing Biogen’s ALS Miss, Plus Califf on Deck
18 oktober 2021 | 23 min
Play
Pause
Ep. 82 - 4Q Markets Preview, Plus the Future of NIH
12 oktober 2021 | 31 min
Play
Pause
Ep. 81 - Merck & the State of M&A, Plus Novartis CEO's Call to Action
5 oktober 2021 | 22 min
Play
Pause
Ep. 80 - Hong Kong Rising, Plus Varmus' POV & Biden's FDA Choice
28 september 2021 | 27 min
Play
Pause
Ep. 79 - ESMO, Jeito & the Latest from Washington
21 september 2021 | 23 min
Play
Pause
Ep. 78 - Remembering Fred Frank, Lisa Raines, Plus CRISPR, Washington Updates
14 september 2021 | 27 min
Play
Pause
Ep. 77 - Back to School Spotlight & Pressures on FDA
4 september 2021 | 22 min
Play
Pause
Ep 76 Pt. 4 - Modifying Access for Accelerated Approvals
1 september 2021 | 14 min
Play
Pause
Ep 76 Pt. 3 - Delivering the Evidence for Accelerated Approval
1 september 2021 | 15 min
Play
Pause
Ep 76 Pt. 2 - Standards of Evidence for Accelerated Approval
30 augusti 2021 | 15 min
Play
Pause
Ep 76 Pt. 1 - Accelerated Approval's Big Picture
30 augusti 2021 | 22 min
Play
Pause
Ep. 75 - Back to School Preview, plus Pfizer Eats Trillium
24 augusti 2021 | 23 min
Play
Pause
Ep. 74 - Vertex's Road Map & Innovation in MS
16 augusti 2021 | 14 min
Play
Pause
Ep. 73 - Next Up in COVID with Otello Stampacchia and Umer Raffat
13 augusti 2021 | 19 min
Play
Pause
Ep. 72 - Modality Matters: M&A Heats Up, Galbraith Maps AZ's BD
9 augusti 2021 | 18 min
Play
Pause
Ep. 71 - Lessons from China’s Market Turmoil, Plus Distillery on Tap
3 augusti 2021 | 27 min
Play
Pause
Ep. 70 - Prepping for China’s IP law with Jones Day’s Tony Chen
29 juli 2021 | 17 min
Play
Pause
Ep. 69 - Allaying Aduhelm Concerns, Plus Master Protocols, Arvinas-Pfizer
27 juli 2021 | 15 min
Play
Pause
Ep. 68 - Drug Pricing Pressure, Plus European Deal Trends
20 juli 2021 | 26 min
Play
Pause
Ep. 67 - Aduhelm: a Tangled Plot; Plus, INTREPID Pandemic Planning
13 juli 2021 | 32 min
Play
Pause
Ep. 66 - Biotechs hit 3Q with Coolers Full of Cash; plus Distillery on Tap
6 juli 2021 | 22 min
Play
Pause
Ep. 65 - Optimism for Intellia's CRISPR Breakthrough, Concerns about Aduhelm
29 juni 2021 | 23 min
Play
Pause
Ep. 64 - Amyloid Analysis: Stress Testing FDA's Logic on Surrogate Endpoint
24 juni 2021 | 19 min
Play
Pause
Ep. 63 - Woodcock, Noubar and Genmab’s dealmaking: A BioCentury Podcast
21 juni 2021 | 25 min
Play
Pause
Ep. 62 - Reflecting on the Implications of Aduhelm's Approval: A BioCentury Podcast
14 juni 2021 | 19 min
Play
Pause
Ep. 61 - Dissecting FDA's Aducanumab Decision
8 juni 2021 | 25 min
Play
Pause
Ep. 60 - D-Day for Aducanumab: What's at stake
2 juni 2021 | 15 min
Play
Pause
Ep. 59 - KRAS to the Future; plus ARPA-H & EGFR
2 juni 2021 | 24 min
Play
Pause
Ep. 58 - LAG3 Before You Leap; plus BEE21, G20 Highlights
24 maj 2021 | 25 min
Play
Pause
Ep. 57 - Financing Scandinavia; plus IP Waivers, Long Covid & AAV Pays
10 maj 2021 | 28 min
Play
Pause
Ep. 56 - FDA’s ODAC Bind; plus NK Cell Engagers and Company Creation in Europe
4 maj 2021 | 21 min
Play
Pause
Ep. 55 - German Plays Deliver on Data, plus Accelerated Approval on Trial
27 april 2021 | 19 min
Play
Pause
Ep. 54 - Patient Groups’ Pandemic Pain; plus Voters’ Rights and Synthetic Lethality
20 april 2021 | 26 min
Play
Pause
Ep. 53 - Competence & Continuity at CDER; plus BIO 3.0, AACR and 2Q Preview
13 april 2021 | 24 min
Play
Pause
Ep. 52 - Memories of John Martin, plus AACR's Hot Targets & Bio€quity Europe Preview
6 april 2021 | 24 min
Play
Pause
Ep. 51 - Abernethy & the Obvious at FDA; Plus CEPI & EpimAb
30 mars 2021 | 18 min
Play
Pause
Ep. 50 - FTC & the Zombie Pharma Dinosaurs; Plus: RIP José Baselga, NCATS & SPACs
23 mars 2021 | 19 min
Play
Pause
Ep. 49 - Vaccine Vexed; Plus Assessing Lilly's Alzheimer's Data & PDUFA Preview
16 mars 2021 | 20 min
Play
Pause
Ep. 48 - New Modality Deep Dive; plus Sharpless Speaks & Five Prime Scores
9 mars 2021 | 20 min
Play
Pause
Ep. 47 - Whither Woodcock; plus Refresh for German Biotech & Modalities to Market
2 mars 2021 | 26 min
Play
Pause
Ep. 46 - Pipeline plays for BMS, Rigel; plus J&J's vaccine panel & access for Africa
23 februari 2021 | 21 min
Play
Pause
Ep. 45 - Start-Up Trends, COVID Variants and J&J's Adcomm
17 februari 2021 | 18 min
Play
Pause
Ep. 44 - Biotech's IPO blizzard, plus GameStop, Porter Report & Vaccine Guidance
9 februari 2021 | 19 min
Play
Pause
Ep. 43 - Europe's Next Act & the Porter Report
2 februari 2021 | 17 min
Play
Pause
Ep. 42 - Warp Speed Reflections, Master Protocols & Biden’s COVID Plan
25 januari 2021 | 16 min
Play
Pause
Ep. 41 - Biden's Science Team; Plus: Early Cancer Detection
20 januari 2021 | 17 min
Play
Pause
Ep. 40 - Investors' Picks & Access to Capital in 2021
15 januari 2021 | 16 min
Play
Pause
Ep. 39 - COVID Accountability, Biden's Bidding & Start-up Season
12 januari 2021 | 15 min
Play
Pause
Ep. 38 - Crucible of COVID, Ahoy 2021 & Cancer Deal Trends
5 januari 2021 | 23 min
Play
Pause
Ep. 37 - 2020's Silver Linings, New Year's Hopes
29 december 2020 | 28 min
Play
Pause
Ep. 36 - Vaccines march forward & CAR Ts move earlier: a BioCentury podcast
15 december 2020 | 18 min
Play
Pause
Ep. 35 - ASH Monday, Biden's Picks & Vaccine Conundrums
8 december 2020 | 24 min
Play
Pause
Ep. 34 - Moderna Moves & Immunocore Breaks Through
1 december 2020 | 20 min
Play
Pause
Ep. 33 - ASH Preview & Long Shot Drug Pricing Rule
24 november 2020 | 21 min
Play
Pause
Ep. 32 - Moderna Times & China's Future
17 november 2020 | 22 min
Play
Pause
Ep. 31 - Pfizer & Biogen: The Good, the bAD and What's Next
10 november 2020 | 23 min
Play
Pause
Ep. 30 - ICER's Influence and Election Effects
3 november 2020 | 17 min
Play
Pause
Ep. 29 - SPACs & Vax
27 oktober 2020 | 20 min
Play
Pause
Ep. 28 - FDA's Future & China Summit Preview
20 oktober 2020 | 20 min
Play
Pause
Ep. 27 - CRISPR advances and mega-IPOs: a BioCentury podcast
13 oktober 2020 | 13 min
Play
Pause
Ep. 26 - Treating Trump & BMS's $13B MyoKardia buy
6 oktober 2020 | 20 min
Play
Pause
Ep. 25 - Alzheimer Milestones & Vaccine Politics
29 september 2020 | 13 min
Play
Pause
Ep. 24 - Azar's Memo & Biotech's Deals
22 september 2020 | 17 min
Play
Pause
Ep. 23 - $21B Deal by Gilead, None by PhRMA
15 september 2020 | 12 min
Play
Pause
Ep. 22 - Back to School, Behind the Scenes
9 september 2020 | 17 min
Play
Pause
Ep. 21 - FDA’s Credibility on the Line, plus Biotech’s Venture Wave
1 september 2020 | 11 min
Play
Pause
Ep. 20 - Politics & Plasma
25 augusti 2020 | 15 min
Play
Pause
Ep. 19 - I Want KaNDy, Plus Sputnik V & M&A amid COVID-19
17 augusti 2020 | 15 min
Play
Pause
Ep. 18 - BIOEquality, Data Sharing and Deals
10 augusti 2020 | 17 min
Play
Pause
Ep. 17 - Warp Speed, Decentralized Trials & SPACs
3 augusti 2020 | 16 min
Play
Pause
Ep. 16 - Trump's Ultimatum, RADx & Preclinical IPOs
27 juli 2020 | 18 min
Play
Pause
Ep. 15 - Vaccine Hopes, the Shifting Biopharma Workplace & Blueprint's Dx Deal
21 juli 2020 | 16 min
Play
Pause
Ep. 14 - Investor Sentiment, HCQ Redux and Attacking AMR
14 juli 2020 | 14 min
Play
Pause
Ep. 13 - Nuances of NASH, COVID Vaccines and Real-World Data
6 juli 2020 | 15 min
Play
Pause
Ep. 12 - Remdesivir's Price, RWD’s Moment & A Genomics Breakup
29 juni 2020 | 11 min
Play
Pause
Ep. 11 - Funding U.K. Biotechs, plus Global Vaccine Access
23 juni 2020 | 16 min
Play
Pause
Ep. 10 - EUAs, ACTIV & M&A
16 juni 2020 | 17 min
Play
Pause
Ep. 9 - IPOs, Vaccines & BIO's New Leader
8 juni 2020 | 14 min
Play
Pause
Ep. 8 - Financing Flurry & Purchasing Pools
1 juni 2020 | 13 min
Play
Pause
Ep. 7 - FDA takes on COVID-19, plus ASCO's breakthroughs
27 maj 2020 | 16 min
Play
Pause
Ep. 6 - New Faces for COVID-19’s Next Phase, ASCO’s Hot Topics
19 maj 2020 | 18 min
Play
Pause
Ep. 5 - Master Protocols, EUAs and Rick Bright: BioCentury editors on COVID-19
12 maj 2020 | 15 min
Play
Pause
Ep. 4 - End of the beginning for vaccines and the post-pandemic future
5 maj 2020 | 16 min
Play
Pause
Ep. 3 - Surveying the Landscape for Biopharmas
28 april 2020 | 15 min
Play
Pause
Ep. 2 - Consorting to beat COVID-19
23 april 2020 | 15 min
Play
Pause
Ep. 1 - Racing to Create Countermeasures
22 april 2020 | 16 min
Ladda fler
Minimera
00:00
-00:00
15
Tillbaka 15 sekunder
Play
Pause
15
Framåt 15 sekunder
15
Tillbaka 15 sekunder
Play
Pause
15
Framåt 15 sekunder
Expandera spelare
Stäng spelare
00:00
-00:00